Coronavirus (COVID-19)Health

FDA Head Issues Apology Amid COVID-19 Plasma Treatment Controversy


Following critical commentary from a range of medical authorities, U.S. Food and Drug Administration (FDA) Commissioner Stephen Hahn issued an apology on Tuesday for an earlier statement exaggerating the potential life-saving attributes of convalescent plasma treatment for those suffering from the novel coronavirus.

On Sunday, President Donald Trump indicated that the FDA had determined that it would issue emergency authorization for the use of plasma extracted from patients already recovered from COVID-19 as a treatment for individuals currently infected with the virus. Trump touted plasma treatment as a groudbreaking milestone in the fight against the coronavirus. This announcement prompted notable pushback from scientists and health professionals who cast doubt on the accuracy of the claims Hahn used to support the administration’s decision.

Read More »

Explore Games and Apps


Related Articles

Back to top button


Get a daily email of trending news and updates. Be the first to see top stories and events.